IL-10 increased secretion in the glioblastoma microenvironment has the effect of amplifying the release of other anti-inflammatory cytokines such as IL-4 and Chemokine C-C motif ligand 2 (CCL2) [58]. This evidence concerns the gene CCL2 and glioblastoma.